Zobrazeno 1 - 10
of 94
pro vyhledávání: '"E, Urbieta Sanz"'
Autor:
P Ortiz Fernandez, M Gil Candel, A Martinez Soto, A Herrero Fernandez, P Fernandez-Villacañas Fernandez, I Salar Valverde, M Garcia Coronel, C Pastor Mondéjar, C Caballero Requejo, E Urbieta Sanz
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e788ef08ba84b90319e0ec4bb58bd1f
https://doi.org/10.1136/ejhpharm-2023-eahp.215
https://doi.org/10.1136/ejhpharm-2023-eahp.215
Autor:
P Ortiz Fernandez, E Urbieta Sanz, M Garcia Coronel, P Fernandez-Villacañas Fernandez, A Martinez Soto
Publikováno v:
Section 4: Clinical pharmacy services.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91e2849eec15faf6f164275a90611562
https://doi.org/10.1136/ejhpharm-2023-eahp.227
https://doi.org/10.1136/ejhpharm-2023-eahp.227
Autor:
A Herreros Fernández, E Urbieta Sanz, P Fernandez-Villacañas Fernandez, P Ortiz Fernandez, AM Martinez Soto
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a30a1f6375429d223b599c32bd0641c6
https://doi.org/10.1136/ejhpharm-2023-eahp.319
https://doi.org/10.1136/ejhpharm-2023-eahp.319
Publikováno v:
Pharmaceutical Care España, Vol 19, Iss 4 (2017)
Externí odkaz:
https://doaj.org/article/30d0a03dcd25436493e01fd02bda57cc
Autor:
AM Martínez Soto, M García Coronel, C Pastor Mondéjar, JM Marco Puig, P Ortiz Fernandez, P Fernández-Villacañas Fernández, C Caballero Requejo, L Rentero Redondo, C Iniesta Navalón, I Salar Valverde, E Urbieta Sanz
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a51dea737afaa4f49a67ad656cbd514e
https://doi.org/10.1136/ejhpharm-2022-eahp.266
https://doi.org/10.1136/ejhpharm-2022-eahp.266
Autor:
AM Martínez Soto, M Garcia Coronel, P Ortiz Fernandez, JM Marco Puig, C Pastor Mondéjar, P Fernandez-Villacañas Fernandez, L Rentero Redondo, C Caballero Requejo, C Iniesta Navalon, I Salar Valverde, E Urbieta Sanz
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dd7f44ab467d641390b1e46d643ce0c
https://doi.org/10.1136/ejhpharm-2022-eahp.268
https://doi.org/10.1136/ejhpharm-2022-eahp.268
Autor:
C Pastor Mondéjar, C Iniesta Navalón, A Martinez Soto, P Ortiz Fernandez, P Ferandez-Villacañas Ferandez, L Rentero Redondo, C Caballero Requejo, M Garcia Coronel, I Salar Valverde, E Urbieta Sanz
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff803a5274a4b6280b898b7e5f3ed348
https://doi.org/10.1136/ejhpharm-2022-eahp.351
https://doi.org/10.1136/ejhpharm-2022-eahp.351
Autor:
C Pastor Mondéjar, C Iniesta Navalón, A Martínez Soto, P Ortiz Fernández, P Ferandez-Villacañas Ferandez, I Salar Valverde, L Rentero Redondo, C Caballero Requejo, M Garcia Coronel, E Urbieta Sanz
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efee6b8a690f7c8407248174c98af5c6
https://doi.org/10.1136/ejhpharm-2022-eahp.314
https://doi.org/10.1136/ejhpharm-2022-eahp.314
Autor:
C Pastor Mondéjar, C Inista Navalón, A Martinez Soto, P Ortiz Fernandez, P Ferandez-Villacañas Ferandez, I Salar Valverde, L Rentero Redondo, E Urbieta Sanz
Publikováno v:
Section 5: Patient safety and quality assurance.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5377fc97e732c0d6335705f8eef13560
https://doi.org/10.1136/ejhpharm-2022-eahp.349
https://doi.org/10.1136/ejhpharm-2022-eahp.349
Autor:
C Iniesta Navalón, C Pastor Mondéjar, Mdc Caballero Requejo, M García Coronel, I Salar Valverde, AM Martínez Soto, E Urbieta Sanz, M Gil Candel, P Ortíz Fernández, A Quesada Asencio, M Onteniente Candela
Publikováno v:
Section 5: Patient safety and quality assurance.
Background and importance Rheumatoid arthritis is a chronic, autoimmune disease, with unknown aetiology, characterised by chronic inflammation of synovial articulations. Biologic disease modifying antirheumatic drugs (bDMARDs) are used to slow down d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ebf5883cde6f83ba5de670ae212e3cc
https://doi.org/10.1136/ejhpharm-2021-eahpconf.298
https://doi.org/10.1136/ejhpharm-2021-eahpconf.298